PTC Therapeutics Inc is a biopharmaceutical company. It is focused on the discovery and development of orally administered, proprietary small-molecule drugs that target post-transcriptional control processes.
$47.30 -0.07 (-0.15%)
As of 02/02/2023 10:06:32 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.